Manning Paul B bought CADL
September 30, 2026 · Form 4 insider transaction
Manning Paul B bought 2,189 shares of Candel Therapeutics, Inc. at $8.68 per share, a transaction worth $19.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,189
Price
$8.68
Total value
$19.0K
InsiderManning Paul B
RoleDirector, 10% owner
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 30, 2026
Filing dateOctober 2, 2026
Shares owned after2,189
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant.